Asr Vermogensbeheer N.V. Neurocrine Biosciences Inc Transaction History
Asr Vermogensbeheer N.V.
- $6.75 Trillion
- Q1 2025
A detailed history of Asr Vermogensbeheer N.V. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Asr Vermogensbeheer N.V. holds 4,208 shares of NBIX stock, worth $461,828. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,208Holding current value
$461,828% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding NBIX
# of Institutions
642Shares Held
94.1MCall Options Held
282KPut Options Held
281K-
Black Rock Inc. New York, NY14.2MShares$1.56 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.09 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$537 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$331 Million0.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.54MShares$279 Million0.06% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $10.5B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...